Navigation Links
Zimmer Reports Fourth Quarter and 2007 Financial Results
Date:1/29/2008

rcises 30.1 11.6

Excess income tax benefits from stock

option exercises (27.0) (8.0)

Changes in operating assets and liabilities

Income taxes 70.0 68.7

Receivables (12.5) (76.9)

Inventories (57.5) (39.2)

Accounts payable and accrued expenses 59.0 (29.9)

Other assets and liabilities (64.6) 6.5

Net cash provided by operating activities 1,070.8 1,040.7

Cash flows provided by (used in)

investing activities

Additions to instruments (138.5) (126.2)

Additions to other property, plant

and equipment (192.7) (142.1)

Proceeds from sale of property,

plant and equipment - 16.2

Acquisitions, net of acquired cash (160.3) (34.9)

Net cash used in investing activities (491.5) (287.0)

Cash flows provided by (used in)

financing activities

Proceeds from employee stock compensation

plans 163.4 41.3

Excess income tax benefits from stock

option exercises 27.0 8.0

Repurchase of common stock (576.3) (798.8)

Net proceeds on lines of credit - 18.8

Net cash used in financing activities (385.9) (730.7)

Effect of exchange rates on cash and

equivalents 4.8 9.5

Increase in cash and equivalents 198.2 32.5

<
'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
2. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
3. Zimmer Holdings to Present at JPMorgan Healthcare Conference
4. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
5. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
6. Zimmer Holdings to Present at Upcoming Investor Conferences
7. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
8. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
9. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
10. Amylin Pharmaceuticals Reports 2007 Financial Results
11. Cystic Fibrosis Foundation reports upward trend for key health outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...k of Peers, Parents and Professionals Shares Exper...n, Employment, Recreation, More , , WASHING...a leading international disability association wor... people with significant disabilities announces th...eer resource directory accessible to people with d...
(Date:12/2/2008)...melteon show it could aid shift workers, people af...ealthDay News) -- The experimental drug tasimelteo... or night shifts, according to the results of two ...ded 39 people randomly assigned to receive either ...on, or a placebo. They were monitored for seven ni...
(Date:12/2/2008)... Dec. 2 MEDai, Inc., headquartered...rovider, has added a new module,to its existing s...and-alone,module monitors a population,s complian...ts stakeholders when there has been a deviation fr... Guidelines(TM) provides,real-time decision suppo...
(Date:12/2/2008)...s Nearly Half Have Skipped Medical Care Due to Cos...swire-USNewswire/ -- A new survey released today b...RC) highlights another troubling aspect of the cur...eek health care for themselves or their families t...men say their health has gotten worse over the pas...
Breaking Medicine News(10 mins):Health News:New Website Links People With Disabilities to Peers for Help 2Health News:Drug Effective for Temporary Sleep Disruptions 2Health News:MEDai Evidence-Based Guideline Reporting Provides Decision Support at Point of Care 2Health News:Rising Health Costs Prompt Women to Neglect Health 2Health News:Rising Health Costs Prompt Women to Neglect Health 3Health News:Rising Health Costs Prompt Women to Neglect Health 4
...sia is catching up fast with the West. Yes, but no...tunately in cancer incidence too. Smoking, drink...ous cancers will combine with larger populations ...ous diseases to drive Asian cancer rates up 60 per...
...wo Philippines examiners were charged with corrupt...mination, officials said, in a scandal that cast ...are the first two people to be charged in connecti... commission issuing a temporary ban on the 17,000 ...
...owerful Shiite politician Abdel Aziz al-Hakim retu...receiving treatment for cancer in Tehran. Hakim, ...e parliament, spent nearly two weeks abroad in a t...cal tests in the United States and treatment in Ir...
...mputees can now breathe a sigh of relief for resea...y (MIT) in Boston have developed two robotic devic...ural, energy-efficient gaits. Dr. Hugh Herr, Assi...Biomechatronics Group at the institute, has been q...
Other Medicine News:Health News:Surge in Cancer Incidence in Asia Feared 2Health News:Surge in Cancer Incidence in Asia Feared 3Health News:Top Iraqi Shiite Leader Returns Home 2Health News:Now, Natural Looking, Energy Efficient Robotic Ankles for Amputees 2
(Date:12/1/2008)...de study shows the Prox1 gene is a two-way switch ...cells to be reprogrammed so that they lose their i...ls , , MEMPHIS, Tenn., Dec. 1 /PRNewswire-U...esearch Hospital have discovered that a certain di...dentity that it requires the constant expression o...
(Date:12/1/2008)...ference Call Scheduled for Tuesday, December 9 at ...L -- , , SOUTH SAN FRANCISCO, Calif., Dec....cals, Inc. (Nasdaq: SNSS ), a biopharmaceutical ...zation of new oncology therapeutics, today announc... myeloid leukemia (AML) will be presented during t...
(Date:11/30/2008)...O, Dec. 1 Abnormalities...ted in children with autism spectrum disorder by u...study presented today at the annual meeting of the... , "Using MEG, we can record the tiny magneti...," said Timothy Roberts, Ph.D., vice chair of rese...
(Date:11/26/2008)...TER, Minn., Nov. 26 Chi...are at significantly increased risk of developing ...ndings of a Mayo Clinic study published this mont...ican Academy of Pediatrics. , , The retrosp...atients with strabismus (misaligned eyes) and comp...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Eye Divergence in Children Triples Risk of Mental Illness 2Wide Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 30401 1Wide Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 30401 2Wide Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 30401 3Wide Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 30401 4Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia 3477 1Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia 3477 2Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia 3477 3Ultrasound waves aid in rapid treatment of DVT 30399 1Ultrasound waves aid in rapid treatment of DVT 30399 2UT Southwestern researchers develop new strategy for broad spectrum anti viral drugs 30397 1UT Southwestern researchers develop new strategy for broad spectrum anti viral drugs 30397 2
...ansurethral Resection,is Well Tolerated in Phase 2...2007 /PRNewswire-FirstCall/ --,Spectrum Pharmaceut... study of EOquin, in non-invasive bladder cancer a...L)-1620 and satraplatin,at the annual meeting of t...t the Los Angeles Convention Center in Los Angeles...
..., 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:AOLS)... at Loma Linda University Medical Center,National...rsity,showing that one of the Company,s metallopor...ection of healthy normal cells in mice,with prosta... study,also showed that the compound did not inter...
Other Medicine Technology:Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 2Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 3Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 4Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 5Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 6Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 7Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 8Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 2Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 3
...sively for the airlines industry:, ,AirSeps A...ured for the airlines to assist their supplemental...everal overseas airlines. With the US governments ...on specific Boeing commercial aircraft, AirSep set...
...p's LifeStyle Portable Oxygen Concentrator is the ...nywhere. At less than 10 lbs (4.5 kg), this unit w... and highly active oxygen patient., ,Operatin...logies of both an oxygen concentrator and an oxyge...
...ers up to 10 LPM of oxygen reducing the delivery c...ts. The M10 is engineered to reduce the cost of pr...parts than any other concentrator on the market. F...p you to reduce expenditure on accessories and unn...
The Hudson RCI oxygen conserving cannula incorporates a patented "split prong" nose design and two oxygen supply tubes with standard connectors. This design provides the utmost control and comfort in
Medicine Products: